123 related articles for article (PubMed ID: 33902214)
1. [Breast ultrasound optimization process analysis based on breast cancer screening for 1 501 753 rural women in China].
Ma L; Lian ZQ; Zhao YX; Di JL; Song B; Ren WH; Miao HZ; Wu JL; Wang Q
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):497-503. PubMed ID: 33902214
[No Abstract] [Full Text] [Related]
2. [Analysis for the breast cancer screening among urban populations in China, 2012-2013].
Mi ZH; Ren JS; Zhang HZ; Li J; Wang Y; Fang Y; Shi JF; Zhang K; Zhao JB; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Oct; 50(10):887-892. PubMed ID: 27686767
[No Abstract] [Full Text] [Related]
3. Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators.
Otten JD; Karssemeijer N; Hendriks JH; Groenewoud JH; Fracheboud J; Verbeek AL; de Koning HJ; Holland R
J Natl Cancer Inst; 2005 May; 97(10):748-54. PubMed ID: 15900044
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening and early diagnosis in China: a systematic review and meta-analysis on 10.72 million women.
Li M; Wang H; Qu N; Piao H; Zhu B
BMC Womens Health; 2024 Feb; 24(1):97. PubMed ID: 38321439
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
Berg WA; Bandos AI; Mendelson EB; Lehrer D; Jong RA; Pisano ED
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712110
[TBL] [Abstract][Full Text] [Related]
6. Preliminary effectiveness of breast cancer screening among 1.22 million Chinese females and different cancer patterns between urban and rural women.
Huang Y; Dai H; Song F; Li H; Yan Y; Yang Z; Ye Z; Zhang S; Liu H; Cao Y; Xiong L; Luo Y; Pan T; Ma X; Wang J; Song X; Leng L; Zhang Y; Sun J; Wang J; Ma H; Kong L; Lei Z; Wang Y; Peishan W; Han J; Hao X; Chen K
Sci Rep; 2016 Dec; 6():39459. PubMed ID: 27995968
[TBL] [Abstract][Full Text] [Related]
7. Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
Vernet-Tomás M; Louro J; Román M; Saladié F; Posso M; Prieto M; Vázquez I; Baré M; Peñalva L; Vidal C; Bargalló X; Sánchez M; Ferrer J; A Espinàs J; Quintana MJ; Rodríguez-Arana A; Castells X;
Maturitas; 2021 Feb; 144():53-59. PubMed ID: 33358209
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
[TBL] [Abstract][Full Text] [Related]
9. Successful first round results of a Turkish breast cancer screening program with mammography in Bahcesehir, Istanbul.
Kayhan A; Gurdal SO; Ozaydin N; Cabioglu N; Ozturk E; Ozcinar B; Aribal E; Ozmen V
Asian Pac J Cancer Prev; 2014; 15(4):1693-7. PubMed ID: 24641392
[TBL] [Abstract][Full Text] [Related]
10. BreastScreen-based mammography screening in women with a personal history of breast cancer, Western Australian study.
Houssami N; Tresham JJ; Fritschi L; Wylie LE
Med J Aust; 2011 Oct; 195(8):460-4. PubMed ID: 22004397
[TBL] [Abstract][Full Text] [Related]
11. Comparison of digital mammography and screen-film mammography in breast cancer screening: a review in the Irish breast screening program.
Hambly NM; McNicholas MM; Phelan N; Hargaden GC; O'Doherty A; Flanagan FL
AJR Am J Roentgenol; 2009 Oct; 193(4):1010-8. PubMed ID: 19770323
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer screening in urban Beijing, 2014-2019].
Yang L; Zhang X; Liu S; Li HC; Zhang Q; Wang N; Ji JF
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):974-980. PubMed ID: 32907288
[No Abstract] [Full Text] [Related]
13. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
14. Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.
van Luijt PA; Fracheboud J; Heijnsdijk EA; den Heeten GJ; de Koning HJ;
Eur J Cancer; 2013 Nov; 49(16):3517-25. PubMed ID: 23871248
[TBL] [Abstract][Full Text] [Related]
15. Comparison of screening mammography in the United States and the United kingdom.
Smith-Bindman R; Chu PW; Miglioretti DL; Sickles EA; Blanks R; Ballard-Barbash R; Bobo JK; Lee NC; Wallis MG; Patnick J; Kerlikowske K
JAMA; 2003 Oct; 290(16):2129-37. PubMed ID: 14570948
[TBL] [Abstract][Full Text] [Related]
16. The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Vreemann S; van Zelst JCM; Schlooz-Vries M; Bult P; Hoogerbrugge N; Karssemeijer N; Gubern-Mérida A; Mann RM
Breast Cancer Res; 2018 Aug; 20(1):84. PubMed ID: 30075794
[TBL] [Abstract][Full Text] [Related]
17. Not all false positive diagnoses are equal: On the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography / digital tomosynthesis screening.
Kuhl CK; Keulers A; Strobel K; Schneider H; Gaisa N; Schrading S
Breast Cancer Res; 2018 Feb; 20(1):13. PubMed ID: 29426360
[TBL] [Abstract][Full Text] [Related]
18. Is Step Down Assessment of screen-detected lesions as safe as workup at a metropolitan assessment centre?
Hughes JP; Jose DC; Tuch GH; Fritschi L; Tresham J; Wylie E
Aust N Z J Public Health; 2014 Feb; 38(1):44-8. PubMed ID: 24494945
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
